Autism and autoimmune diseases and high-dose Vitamin D - video and summary
Why Vitamin D Therapy for Autism is a Game Changer | Cure4Pain x Natsayi Dunira
Cure4Pain: summarized by Claude AI, June 2026
(00:00–03:13) Host Natsayi Dunira (naturopathic nutritionist) opens by linking the rising prevalence of autism, MS, lupus, and depression to a common denominator she identifies as vitamin D deficiency, framing the episode around vitamin D as a "game changer."
(03:13–08:00) Guests Dr. Khushal Pabari (pharmacologist/rheumatologist) and Chintan Dalal (naturopath, orthomolecular medicine, Mumbai) describe how a 2017 conversation triggered them to systematically test and treat patients with vitamin D plus co-actors (magnesium, zinc, boron, K2, B vitamins, trace minerals), running frequent blood panels on 5,000+ patients between 2018–2021.
(08:00–11:30) Natsayi shares that despite seeking autism treatment globally for her son, no clinician ever checked his vitamin D; she now finds nearly 100% of her autism clients are vitamin D deficient, with symptoms fading when levels rise and returning when they drop.
(11:30–17:00) Dr. Pabari explains the biochemistry: vitamin D is required for synthesis of dopamine, acetylcholine, and serotonin; it has a 72-hour half-life requiring constant supply; toxicity claims are overstated and hypercalcemia/kidney stones only occur with unmonitored dosing lacking co-actors like K2 and magnesium.
(17:00–22:00) They argue the standard "30–100 ng/mL" reference range applies only to bone health — autoimmune, neurological, and metabolic conditions often require levels of 120–150, individually titrated via repeat blood work rather than one-size-fits-all dosing.
(22:00–25:30) Case example: a 2.5-year-old with severe eczema/psoriatic patches (vitamin D level of 4) saw 70% clearance in 7 days and full resolution at 45 days when levels were sustained above 80; they stress that intermittent "seesaw" dosing prevents healing because the body needs continuous raw material.
(25:30–32:00) Vitamin D's role in neuroplasticity, mood, and cognition is discussed, including a cited meta-analysis showing 40% higher neurological disorder incidence in unsupplemented groups; Natsayi shares her own 2017 recovery from severe depression after correcting her vitamin D, avoiding prescribed citalopram.
(32:00–43:30) Mold and fungal infections are presented as a major hidden driver of autoimmunity and psychiatric symptoms (including a schizophrenia case in a 23-year-old resolved in 6 weeks by treating monocytes/fungi); they note fungi block vitamin D receptors and that bloodwork only shows surface-level data, with deeper infections often revealed after initial cleanses.
(43:30–53:00) The protocol outline: aggressive vitamin D loading with titrated co-actors, a 6–8 week rotational antiparasitic/antiviral/antifungal/antibacterial gut cleanse, blood retests every 25 days for the first 3 months, with a "healing crisis" expected in days 5–7; sunlight alone (even in sunny countries) is insufficient due to required UVB exposure windows, pollution, and indoor lifestyles.
(53:00–1:09:18) Closing points: high vitamin D rarely causes hypercalcemia when K2/magnesium are co-supplemented; supplement quality and avoidance of fillers matter enormously; vitamin D below 60 ng/mL puts the body in a "hibernation/winter" state driving obesity and fatigue; treatment must be physician-supervised and treated as drug therapy, not casual supplementation, with attention to B vitamins and copper alongside the standard co-actors.
Note: This is a single-perspective clinical podcast. The claim that "97% of ailments disappear with vitamin D" and the very high target ranges (120–150 ng/mL) cited here exceed mainstream endocrine society guidelines and the published Coimbra Protocol literature — worth flagging if you're considering content for VitaminDWiki given your editorial standard around evidence tiering and RCT vs. observational separation.